Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0099) | |||||
---|---|---|---|---|---|
DME Name | Cholesterol desmolase (CYP11A1), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.14.15.6 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification Healthy | |||||
ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 6 HOSPPI | ||||
Oligomerization | |||||
Cytochrome b5 (CYB5A) | Health | Heterodimer | |||
Uniprot ID | |||||
Interaction Name | CYB5A-CYP11A1 heterodimerization | [1] | |||
Studied Cell Lines | Escherichia coli cell line | ||||
Description | Cytochrome b5 (CYB5A) is reported to heterodimerize with the CYP11A1 protein, which has no effect on the enzyme activity of Cholesterol desmolase. As a result, the interaction between CYB5A and CYP11A1 can have no effect on the drug-metabolizing process of Cholesterol desmolase. | ||||
Transcription-factor regulation | |||||
Erythroid TF factor (GATA1) | Health | Activation | |||
Uniprot ID | |||||
Interaction Name | GATA1-CYP11A1 interaction | [2] | |||
Studied Cell Lines | Adrenal cortex and testicular Leydig cell line | ||||
Description | Erythroid TF factor (GATA1) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between GATA1 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
Lipopolysaccharide-binding (LBP) | Health | Activation | |||
Uniprot ID | |||||
Interaction Name | LBP-CYP11A1 interaction | [2] | |||
Studied Cell Lines | Adrenal cortex and testicular Leydig cell line | ||||
Description | Lipopolysaccharide-binding (LBP) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between LBP and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
Nuclear receptor family 0 B1 (NR0B1) | Health | Activation | |||
Uniprot ID | |||||
Interaction Name | NR0B1-CYP11A1 interaction | [2] | |||
Studied Cell Lines | Adrenal cortex and testicular Leydig cell line | ||||
Description | Nuclear receptor family 0 B1 (NR0B1) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between NR0B1 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
Steroidogenic factor 1 (NR5A1) | Health | Activation | |||
Uniprot ID | |||||
Interaction Name | NR5A1-CYP11A1 interaction | [2] | |||
Studied Cell Lines | Adrenal cortex and testicular Leydig cell line | ||||
Description | Steroidogenic factor 1 (NR5A1) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between NR5A1 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
Zinc finger protein rapa (TRERF1) | Health | Activation | |||
Uniprot ID | |||||
Interaction Name | TRERF1-CYP11A1 interaction | [2] | |||
Studied Cell Lines | Adrenal cortex and testicular Leydig cell line | ||||
Description | Zinc finger protein rapa (TRERF1) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between TRERF1 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Third ventricle chordoid glioma | Significant hypermethylation | |||
Interaction Name | DNMT-CYP11A1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 7.09E-04; delta-beta: 6.58E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CYP11A1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between DNMT and CYP11A1 can significantly affect the drug-metabolizing process of Cholesterol desmolase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypomethylation | |||
Interaction Name | DNMT-CYP11A1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 2.74E-11; delta-beta: -4.31E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CYP11A1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between DNMT and CYP11A1 can significantly affect the drug-metabolizing process of Cholesterol desmolase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2D11 Adrenocortical carcinoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
Splicing factor 1 (SF1) | Adrenocortical carcinoma | Activation | |||
Uniprot ID | |||||
Interaction Name | SF1-CYP11A1 interaction | [3] | |||
Studied Cell Lines | Y1 adrenocortical cell line | ||||
Description | Splicing factor 1 (SF1) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between SF1 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
ICD-11: 5A80 Polycystic ovary syndrome | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
TF factor GATA-6 (GATA6) | Polycystic ovary syndrome | Activation | |||
Uniprot ID | |||||
Interaction Name | GATA6-CYP11A1 interaction | [4] | |||
Studied Cell Lines | PCOS theca cell line | ||||
Ensembl ID | |||||
Description | TF factor GATA-6 (GATA6) is reported to activate the transcription of CYP11A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between GATA6 and CYP11A1 can activate the drug-metabolizing process of Cholesterol desmolase. | ||||
ICD Disease Classification 16 Genitourinary system diseases | |||||
ICD-11: GA30 Menopausal disorder | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
Forkhead box protein L2 (FOXL2) | Menopausal disorder | Repression | |||
Uniprot ID | |||||
Interaction Name | FOXL2-CYP11A1 interaction | [5] | |||
Studied Cell Lines | CHO cell line | ||||
Ensembl ID | |||||
Description | Forkhead box protein L2 (FOXL2) is reported to repress the transcription of CYP11A1 gene, which leads to a decreased expression of the drug-metabolizing enzyme Cholesterol desmolase. As a result, the interaction between FOXL2 and CYP11A1 can repress the drug-metabolizing process of Cholesterol desmolase. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.